Armando Anido
2019
In 2019, Armando Anido earned a total compensation of $1.4M as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $334,112 |
---|---|
Option Awards | $413,149 |
Salary | $568,218 |
Other | $54,092 |
Total | $1,369,571 |
Anido received $568.2K in salary, accounting for 41% of the total pay in 2019.
Anido also received $334.1K in non-equity incentive plan, $413.1K in option awards and $54.1K in other compensation.
Rankings
In 2019, Armando Anido's compensation ranked 7,786th out of 13,971 executives tracked by ExecPay. In other words, Anido earned more than 44.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,786 | 44th |
Manufacturing | 3,058 | 46th |
Chemicals And Allied Products | 1,154 | 48th |
Drugs | 986 | 48th |
Pharmaceutical Preparations | 733 | 48th |
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2019.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019